GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

Today
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Lupin Ltd
Buyback of Shares by Multicare Pharmaceuticals Philippines Inc., a subsidiary company.
BUYBACK ● No Immediate Change LOW RISK
📅 Filed on BSE: 30 Mar 2026, 09:45 AM IST  ·  BSE ID: 2d46db78-f7c8-4692-86ce-49960b60ebeb
View Original BSE Filing (PDF)
💡
In Simple Terms
Lupin's Philippines pharmaceutical subsidiary increased its parent company's ownership stake through a share buyback from other shareholders using its own cash.
🤖 AI Summary
  • Multicare Pharmaceuticals Philippines (MPPI) bought back 2,813,811 equity shares using retained earnings
  • Nanomi B.V. shareholding in MPPI increased from 51% to 56.28% effective March 30, 2026
  • MPPI turnover PHP 2,096.6 million; net worth PHP 1,265.5 million as of March 31, 2025
  • Not a related-party transaction; Nanomi did not participate in the share buyback
🔢 Key Numbers — exact figures from BSE filing, not rounded
Shares bought back by MPPI
2,813,811 equity shares
Nanomi shareholding increase in MPPI
51% to 56.28%
MPPI turnover (as of March 31, 2025)
PHP 2,096.6 million
MPPI net worth (as of March 31, 2025)
PHP 1,265.5 million
🏢 How This Affects the Company
💰
Financial Impact
Nanomi's increased ownership stake in MPPI (51% to 56.28%) consolidates control without additional cash outlay from Lupin, as MPPI funded the buyback from retained earnings.
👥 What This Means For Shareholders
Action Required
No action required. This is a subsidiary-level corporate restructuring disclosed for transparency under Regulation 30.
👤
Who Is Affected
Lupin shareholders indirectly — Nanomi B.V. (wholly owned by Lupin) strengthens control of MPPI, a subsidiary engaged in Philippine pharmaceutical distribution.
🔍
Management Signal
Management executed disciplined capital deployment by increasing ownership concentration through subsidiary-funded buyback rather than parent capital infusion.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
MPPI financial results — check if PHP 2,096.6 million annual turnover sustains in FY26
Nanomi shareholder reporting — monitor if further stake consolidation announced in next disclosures
Dividend flow from MPPI — track upstream cash movement to parent Lupin if initiated
LOW RISK Buyback funded from MPPI retained earnings; no parent debt incurred. Subsidiary remains profitable with PHP 1,265.5 million net worth.
💡 Investor Takeaway
MPPI buyback increased Nanomi's stake to 56.28% using subsidiary retained earnings (PHP 2,096.6 million turnover). No related-party transaction. Lupin maintains control via Nanomi without incremental capital deployment.
⚖️ Strengths & Concerns

✅ Positives

  • Buyback achieved without Nanomi cash contribution, preserving parent company liquidity for other investments
  • MPPI maintains profitable operations with PHP 2,096.6 million turnover and PHP 1,265.5 million net worth
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.